Recent analyst commentary has emphasized Viking Therapeutics' advanced clinical programs in the obesity and metabolic disease space, spotlighting the company as an independent player in a ...

Viking Therapeutics, Inc. (VKTX) closed at $27.88 in the latest trading session, marking a +1.86% move from the prior day. This move outpaced the S&P 500's daily gain of 0.06%. Meanwhile, the Dow ...